John R Ingram

Summary

Country: UK

Publications

  1. doi request reprint Occupational allergic contact dermatitis to polyfunctional aziridine crosslinker in a 'tufter'
    John R Ingram
    Department of Occupational Dermatology, Royal Gwent Hospital, Newport NP20 2UB, UK
    Contact Dermatitis 58:172-3. 2008
  2. doi request reprint Nicotine: does it have a role in the treatment of skin disease?
    J R Ingram
    Department of Dermatology, University Hospital of Wales, Cardiff, UK
    Postgrad Med J 85:196-201. 2009
  3. doi request reprint Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis
    John R Ingram
    Department of Dermatology, Cardiff University School of Medicine, Heath Park, Cardiff, UK
    Am J Clin Dermatol 10:229-37. 2009
  4. doi request reprint Management of acne vulgaris: an evidence-based update
    J R Ingram
    Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK
    Clin Exp Dermatol 35:351-4. 2010

Collaborators

Detail Information

Publications4

  1. doi request reprint Occupational allergic contact dermatitis to polyfunctional aziridine crosslinker in a 'tufter'
    John R Ingram
    Department of Occupational Dermatology, Royal Gwent Hospital, Newport NP20 2UB, UK
    Contact Dermatitis 58:172-3. 2008
  2. doi request reprint Nicotine: does it have a role in the treatment of skin disease?
    J R Ingram
    Department of Dermatology, University Hospital of Wales, Cardiff, UK
    Postgrad Med J 85:196-201. 2009
    ..Randomised controlled trials of nicotine preparations in those skin conditions that occur less often in smokers are necessary to establish the value of nicotine, if any, in the treatment of skin disease...
  3. doi request reprint Impact of topical calcineurin inhibitors on quality of life in patients with atopic dermatitis
    John R Ingram
    Department of Dermatology, Cardiff University School of Medicine, Heath Park, Cardiff, UK
    Am J Clin Dermatol 10:229-37. 2009
    ..QOL data comparing topical calcineurin inhibitors with other active treatments such as topical corticosteroids are sparse and it would be useful for future randomized trials to include QOL measures as a primary outcome...
  4. doi request reprint Management of acne vulgaris: an evidence-based update
    J R Ingram
    Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK
    Clin Exp Dermatol 35:351-4. 2010
    ..Trials need to shift from using multiple, unvalidated outcome measures to including patient-reported and quality-of-life outcomes, and all trials should be registered on a public clinical-trials database...